Cargando…
Geroscience in the Age of COVID-19
The data on COVID-19 is clear on at least one point: Older adults are most vulnerable to hospitalization, disability and death following infection with the novel coronavirus. Therefore, therapeutically addressing degenerative aging processes as the main risk factors appears promising for tackling th...
Autores principales: | Barzilai, Nir, Appleby, James C, Austad, Steven N, Cuervo, Ana Maria, Kaeberlein, Matt, Gonzalez-Billault, Christian, Lederman, Stephanie, Stambler, Ilia, Sierra, Felipe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390533/ https://www.ncbi.nlm.nih.gov/pubmed/32765937 http://dx.doi.org/10.14336/AD.2020.0629 |
Ejemplares similares
-
CLINICAL TRIALS IN GEROSCIENCE
por: Kaeberlein, Matt, et al.
Publicado: (2019) -
Geroscience and the challenges of aging societies
por: Sierra, Felipe
Publicado: (2019) -
Evaluating Health Span in Preclinical Models of Aging and Disease: Guidelines, Challenges, and Opportunities for Geroscience
por: Huffman, Derek M., et al.
Publicado: (2016) -
Geroscience approaches to obesity
por: Bitto, Alessandro, et al.
Publicado: (2021) -
PRESIDENTIAL SYMPOSIUM: EXPANDING THE GEROSCIENCE NETWORK
por: Kaeberlein, Matt
Publicado: (2019)